Clinical trial Recruiting at 1 site Interventional Ages 4 to 16

Exploring treatments for amblyopia in children using OCT technology

Official title: OCT Eccentric Fixation, Fixation Stability, and Amblyopia in Children

Run by State University of New York College of Optometry · NCT05714449 · Data updated 2026-11-12

This study is testing different treatments for amblyopia in children aged 4-16 to see how well they improve vision using eye patches and foveation therapy.

Quick facts

Study typeInterventional
Ages4 Years to 16 Years
SexAll
Enrollment30 (estimated)
SponsorState University of New York College of Optometry
Academic / other
Locations1 site (New York, New York)
StatusRecruiting
StartedJanuary 25, 2023
Main results expectedFebruary 24, 2027
Study endsMarch 24, 2027
Registry record updatedOctober 8, 2026
Trial IDNCT05714449 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are children aged 4-16 with amblyopia characterized by specific visual acuity and ocular conditions.

Probably not a fit

Patients with amblyopia not meeting the inclusion criteria or those with other ocular conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the relationship between OCT eccentric fixation and various treatment methods for amblyopia in children. It aims to assess changes in fixation eye movement and macular sensitivity following patching treatment and foveation therapy over a 12-week period. The study will enroll children aged 4-16 with specific types of amblyopia, utilizing interventions such as eye patches and foveation therapy to evaluate their effectiveness. The outcomes will help to better understand how these treatments impact visual function in affected children.

Why it matters

Potential benefit: If successful, this study could lead to improved treatment strategies for amblyopia, enhancing visual outcomes in children.

How similar studies have gone: While there have been studies on amblyopia treatments, the specific use of OCT eccentric fixation in this context is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. children with best-corrected visual acuity (BCVA) of 20/40 (equivalent to 0.3 logMAR) or worse in the amblyopic eye (ranging from 20/40 to 20/400), and interocular difference of BCVA was at least two logMAR lines,
2. ocular causes of amblyopia that were identified as refractive(i.e., anisometropic, strabismus, or strabismic-anisometropic.

   * Anisometropia included interocular difference of spherical equivalent \>=1D or interocular difference of astigmatism cylinder magnitude \>=1D;
   * strabismus included those with deviation \>=10PD or good alignment after prior strabismus surgery;
   * combined type included those who meet the criteria of both anisometropia and strabismus.
   * For the patching group, we will enroll 15 children with strabismic amblyopia who are prescribed patching treatment. Age: 4-12 years old.
   * For the foveation therapy group, we will enroll 15 children with strabismic amblyopia who are prescribed foveation therapies. Age: 8-16 years old.

Exclusion Criteria:

* born before 32 weeks gestational age;
* neurologic, developmental, or systemic illnesses known to be associated with ocular pathologies;
* congenital or acquired macular pathology.

Where it's running

  • SUNY College of Optometry
    New York, New York, United States
    Recruiting

Study contacts

  • Principal investigator: Jingyun Wang — SUNY College of Optmetry
  • Study coordinator: Jingyun Wang, PhD
  • Email: jwang@sunyopt.edu
  • Phone: 2129385759

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.